RecruitingNot Applicable

Xanthohumol and Viral Infections (XL)

Austria100 participantsStarted 2023-08-01

Plain-language summary

The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy * BMI \>18 kg/m² or \< 28kg/m² Exclusion Criteria: * food intolerances * food allergies * chronic inflammatory diseases * metabolic diseases * viral or bacterial infections within the last 3 weeks of inclusion * intake of immunosuppressive medication * severe acute respiratory syndrome coronavirus type 2-infection in the last 4 months * influenza infection in the "current" flu season

What they're measuring

Changes in severity and duration of viral infections

Timeframe: 90 days

Trial details

NCT IDNCT06286657

SponsorUniversity of Vienna

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-31

Contact for this trial

Ina Bergheim, Prof. Dr.

+43-1-4277-54981 ina.bergheim@univie.ac.at

View on ClinicalTrials.gov More Infection Viral trials